Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | McCarthy Brian K.Pres.,Global Sales & Field Ops | Open-market sale · 10b5-1 plan | SELL | $140K 2,000 sh | Jan 13, 2026 |
| 11 | Francis John Milton IVChief Operating Officer | Grant or award | A | — 75.0K sh | Jan 13, 2026 traded Jan 8, 2026 |
| 11 | Baig SaqibChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $35K 5,000 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Thygesen Allan C.Director, President and CEO | Open-market sale · 10b5-1 plan | SELL | $21K 300 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Litinsky James H.Director, Chairman and CEO | Grant or award | A | — 65.4K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $16K 30 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $48K 89 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $21K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | Open-market sale · 10b5-1 plan | SELL | $43K 80 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Taub RebeccaDirector | Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 10 | Friedman Paul ADirector | Open-market sale · 10b5-1 plan | SELL | $22K 40 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Vorakoun LisaSVP & CHIEF ACCOUNTING OFFICER | Tax withholding | F | $30K 1,635 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Blasing KarenDirector | Grant or award | A | — 1,076 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Follmann ChristianChief Operating Officer | Tax withholding | F | $22K 1,178 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 9 | Imam TariqSVP, Bus Dev, General Counsel | Tax withholding | F | $2,760 1,401 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Buck Kristen KEVP, R&D and CMO | Tax withholding | F | $5,875 2,982 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Fasano Gerard ADirector | Grant or award | A | — 838 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Hanson Eric ACFO | Tax withholding | F | $39K 1,720 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Dolan John JosephChief Financial Officer | Tax withholding | F | $2,156 539 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Galimi Gavin G.SVP, General Counsel & Secr. | Tax withholding | F | $3,864 966 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Burrows Scott LChief Financial Officer | Grant or award | A | — 140.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Botelho Kiersten ZazaChief Legal Officer & CCO | Tax withholding | F | $15K 822 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 9 | Buck Kristen KEVP, R&D and CMO | Tax withholding | F | $6,345 3,221 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Doogan DeclanDirector | Grant or award | A | — 30.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Hanson Eric ACFO | Option exercise | M | — 2,488 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Friedman Paul ADirector | Option exercise · 10b5-1 plan | M | $387K 24.5K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Hunter RobynDirector | Grant or award | A | — 30.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Choi EmiliePresident & COO | Grant or award | A | — 160.8K sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Fazio JuliePresident of Subsidiary | Option exercise | M | — 1,350 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 9 | Sloan SheldonChief Medical Officer | Grant or award | A | — 140.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Wagner Paul A.Director, SEE REMARKS | Grant or award | A | — 180.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 9 | Fazio JuliePresident of Subsidiary | Tax withholding | F | $30K 805 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 9 | VanHimbergen Robert MEVP and CFO | Grant or award | A | $190 8 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Buck Kristen KEVP, R&D and CMO | Tax withholding | F | $5,875 2,982 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Nisco JamesSVP, Fin/Treas, Chief Actg Off | Tax withholding | F | $1,539 781 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 9 | Semler DakotaDirector, Chief Executive Officer | Tax withholding | F | $12K 5,620 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 9 | Barbeau Michelle MarieChief Revenue Officer | Tax withholding | F | $1,516 379 sh | Jan 13, 2026 traded Jan 10, 2026 |